Identification of Fatty Acid Amide Hydrolase as a Metastasis Suppressor in Breast Cancer

Scientists reported that the lipid-degrading enzyme fatty acid amide hydrolase was a predictor of long-term survival in patients with luminal breast cancer (BC), and that it blocked tumor progression and lung metastasis in cell and mouse models of BC.